News
Roche begins phase 3 trial of Actemra in COVID-19 pneumonia
Roche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with severe COVID-19 pneumonia, following independent research in China suggesting it may
